JNJ Johnson & Johnson
NYSE · SEC CIK 200406 · EDGAR
- Bought, last 12 months
- $257.7K 1 purchases by 1 insiders
- Sold, last 12 months
- $154.85M 16 sales by 10 insiders
- Filings on record
- 335 since 2021-09-09, latest 2026-09-10 20:51
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Duato Joaquin | CEO, COB, Dir | — | $66.84M |
| Wolk Joseph J | EVP, CFO | — | $21.77M |
| REED JOHN C | EVP, Innovative Medicine, R, D | — | $17.29M |
| Swanson James D. | EVP, CIO | — | $15.11M |
| Schmid Timothy | EVP, WW COB, MedTech | — | $15.08M |
| Broadhurst Vanessa | EVP, Gbl Corp Affairs | — | $7.30M |
| Forminard Elizabeth | EVP, CLO | — | $4.09M |
| Taubert Jennifer L | EVP, WWC. Innovative Medicine | — | $3.95M |
| Wengel Kathryn E | EVP, Chief TO, Risk Off | — | $2.41M |
| Decker Robert J | VP Corp. Ctrl | — | $1.01M |
Transactions 353
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-11 19:42 | 2025-02-07 | JNJ | Wengel Kathryn E | EVP, Chief TO, Risk Off | F - Tax | $153.12 | -26.1K | 89.0K | -23% | -$3.99M |
| D | 2025-02-11 19:41 | 2025-02-07 | JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M - OptEx | $100.06 | +58.5K | 213.4K | +38% | +$5.85M |
| D | 2025-02-11 19:41 | 2025-02-07 | JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F - Tax | $153.12 | -47.4K | 165.9K | -22% | -$7.26M |
| D | 2025-02-11 19:40 | 2025-02-07 | JNJ | Wolk Joseph J | EVP, CFO | M - OptEx | $100.06 | +13.0K | 13.0K | New | +$1.30M |
| D | 2025-02-11 19:40 | 2025-02-07 | JNJ | Wolk Joseph J | EVP, CFO | S - Sale+OE | $153.89 | -13.0K | 0 | -100% | -$2.00M |
| 2024-12-12 17:27 | 2024-12-12 | JNJ | WEINBERGER MARK A | Dir | P - Purchase | $147.22 | +1,000 | 1,000 | New | +$147.2K | |
| DA | 2024-10-31 17:57 | 2024-05-01 | JNJ | REED JOHN C | EVP, Innovative Medicine, R, D | M - OptEx | $0.00 | +25.3K | 25.6K | +8,253% | $0 |
| DA | 2024-10-31 17:57 | 2024-05-01 | JNJ | REED JOHN C | EVP, Innovative Medicine, R, D | F - Tax | $144.59 | -11.0K | 14.6K | -43% | -$1.59M |
| M | 2024-10-21 18:18 | 2024-05-22+ | JNJ | Wolk Joseph J | EVP, CFO | G - Gift | $0.00 | -68.9K | 0 | -100% | $0 |
| I | 2024-10-21 18:18 | 2024-10-17 | JNJ | Wolk Joseph J | EVP, CFO | G - Gift | $0.00 | +68.8K | 68.8K | New | $0 |
| D | 2024-09-03 16:48 | 2024-08-30 | JNJ | Decker Robert J | VP Corp. Ctrl | M - OptEx | $100.06 | +5,635 | 24.6K | +30% | +$563.8K |
| D | 2024-09-03 16:48 | 2024-08-30 | JNJ | Decker Robert J | VP Corp. Ctrl | S - Sale+OE | $165.06 | -5,635 | 19.0K | -23% | -$930.1K |
| D | 2024-07-09 17:48 | 2024-07-08 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Affairs | M - OptEx | $0.00 | +9,809 | 24.9K | +65% | $0 |
| D | 2024-07-09 17:48 | 2024-07-08 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Affairs | F - Tax | $147.16 | -5,018 | 19.8K | -20% | -$738.4K |
| D | 2024-05-03 16:31 | 2024-05-01 | JNJ | REED JOHN C | EVP, Innovative Medicine, R, D | M - OptEx | $0.00 | +22.3K | 22.6K | +7,273% | $0 |
| D | 2024-05-03 16:31 | 2024-05-01 | JNJ | REED JOHN C | EVP, Innovative Medicine, R, D | F - Tax | $144.59 | -11.0K | 11.6K | -49% | -$1.59M |
| 2024-03-13 16:36 | 2024-03-13 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Affairs | S - Sale | $162.16 | -8,891 | 15.0K | -37% | -$1.44M | |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Wengel Kathryn E | EVP, Chief TO, Risk Off | M - OptEx | $0.00 | +651 | 82.6K | +0.8% | $0 |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Wengel Kathryn E | EVP, Chief TO, Risk Off | F - Tax | $157.85 | -333 | 82.3K | -0.4% | -$52.6K |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Wolk Joseph J | EVP, CFO | M - OptEx | $0.00 | +1,780 | 69.7K | +3% | $0 |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Wolk Joseph J | EVP, CFO | F - Tax | $157.85 | -773 | 68.9K | -1% | -$122.0K |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M - OptEx | $0.00 | +1,302 | 155.5K | +0.8% | $0 |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F - Tax | $157.85 | -666 | 154.9K | -0.4% | -$105.1K |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Swanson James D. | EVP, CIO | M - OptEx | $0.00 | +447 | 14.8K | +3% | $0 |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Swanson James D. | EVP, CIO | F - Tax | $157.85 | -195 | 14.6K | -1% | -$30.8K |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Schmid Timothy | EVP, WW COB, MedTech | M - OptEx | $0.00 | +499 | 13.3K | +4% | $0 |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Schmid Timothy | EVP, WW COB, MedTech | F - Tax | $157.85 | -250 | 13.0K | -2% | -$39.5K |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Fasolo Peter | EVP, Chief HR Off | M - OptEx | $0.00 | +925 | 112.5K | +0.8% | $0 |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Fasolo Peter | EVP, Chief HR Off | F - Tax | $157.85 | -474 | 112.1K | -0.4% | -$74.8K |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Hait William | See Remarks | M - OptEx | $0.00 | +834 | 39.1K | +2% | $0 |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Hait William | See Remarks | F - Tax | $157.85 | -427 | 38.6K | -1% | -$67.4K |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Duato Joaquin | CEO, COB, Dir | M - OptEx | $0.00 | +3,470 | 364.8K | +1.0% | $0 |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Duato Joaquin | CEO, COB, Dir | F - Tax | $157.85 | -1,507 | 363.3K | -0.4% | -$237.9K |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Forminard Elizabeth | GC, Executive VP | M - OptEx | $0.00 | +651 | 8,576 | +8% | $0 |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Forminard Elizabeth | GC, Executive VP | F - Tax | $157.85 | -236 | 8,340 | -3% | -$37.3K |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Affairs | M - OptEx | $0.00 | +408 | 24.1K | +2% | $0 |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Affairs | F - Tax | $157.85 | -209 | 23.9K | -0.9% | -$33.0K |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Decker Robert J | VP Corp. Ctrl | M - OptEx | $0.00 | +313 | 19.1K | +2% | $0 |
| D | 2024-02-15 16:53 | 2024-02-13 | JNJ | Decker Robert J | VP Corp. Ctrl | F - Tax | $157.85 | -86 | 19.0K | -0.5% | -$13.6K |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Affairs | M - OptEx | $0.00 | +4,701 | 25.1K | +23% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Affairs | A - Grant | $0.00 | +790 | 25.9K | +3% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Affairs | F - Tax | $157.40 | -2,136 | 23.7K | -8% | -$336.2K |
| DM | 2024-02-14 18:36 | 2024-02-12 | JNJ | Hait William | See Remarks | M - OptEx | $0.00 | +8,932 | 42.3K | +27% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Hait William | See Remarks | F - Tax | $157.40 | -4,076 | 38.2K | -10% | -$641.6K |
| DM | 2024-02-14 18:36 | 2024-02-12 | JNJ | Wolk Joseph J | EVP, CFO | M - OptEx | $0.00 | +25.8K | 78.7K | +49% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Wolk Joseph J | EVP, CFO | F - Tax | $157.40 | -10.8K | 67.9K | -14% | -$1.70M |
| DM | 2024-02-14 18:36 | 2024-02-12 | JNJ | Forminard Elizabeth | GC, Executive VP | M - OptEx | $0.00 | +2,859 | 8,959 | +47% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Forminard Elizabeth | GC, Executive VP | F - Tax | $157.40 | -1,034 | 7,925 | -12% | -$162.8K |
| DM | 2024-02-14 18:36 | 2024-02-12 | JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | M - OptEx | $0.00 | +26.2K | 167.6K | +19% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Taubert Jennifer L | EVP, WWC. Innovative Medicine | F - Tax | $157.40 | -13.4K | 154.2K | -8% | -$2.11M |
| DM | 2024-02-14 18:36 | 2024-02-12 | JNJ | Fasolo Peter | EVP, Chief HR Off | M - OptEx | $0.00 | +15.0K | 118.6K | +14% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Fasolo Peter | EVP, Chief HR Off | F - Tax | $157.40 | -7,019 | 111.6K | -6% | -$1.10M |
| DM | 2024-02-14 18:36 | 2024-02-12 | JNJ | Swanson James D. | EVP, CIO | M - OptEx | $0.00 | +5,456 | 16.0K | +52% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Swanson James D. | EVP, CIO | F - Tax | $157.40 | -1,695 | 14.3K | -11% | -$266.8K |
| DM | 2024-02-14 18:36 | 2024-02-12 | JNJ | Duato Joaquin | CEO, COB, Dir | M - OptEx | $0.00 | +36.6K | 377.2K | +11% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Duato Joaquin | CEO, COB, Dir | F - Tax | $157.40 | -15.9K | 361.3K | -4% | -$2.50M |
| DM | 2024-02-14 18:36 | 2024-02-12 | JNJ | Schmid Timothy | EVP, WW COB, MedTech | M - OptEx | $0.00 | +5,736 | 15.7K | +58% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Schmid Timothy | EVP, WW COB, MedTech | F - Tax | $157.40 | -2,887 | 12.8K | -18% | -$454.4K |
| DM | 2024-02-14 18:36 | 2024-02-12 | JNJ | Decker Robert J | VP Corp. Ctrl | M - OptEx | $0.00 | +1,912 | 19.3K | +11% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Decker Robert J | VP Corp. Ctrl | F - Tax | $157.40 | -523 | 18.7K | -3% | -$82.3K |
| DM | 2024-02-14 18:36 | 2024-02-12 | JNJ | Wengel Kathryn E | EVP, Chief TO, Risk Off | M - OptEx | $0.00 | +13.8K | 89.0K | +18% | $0 |
| D | 2024-02-14 18:36 | 2024-02-12 | JNJ | Wengel Kathryn E | EVP, Chief TO, Risk Off | F - Tax | $157.40 | -7,066 | 81.9K | -8% | -$1.11M |
| D | 2024-02-13 17:18 | 2024-02-09 | JNJ | Wengel Kathryn E | EVP, Chief TO, Risk Off | M - OptEx | $90.44 | +35.6K | 102.5K | +53% | +$3.22M |
| D | 2024-02-13 17:18 | 2024-02-09 | JNJ | Wengel Kathryn E | EVP, Chief TO, Risk Off | F - Tax | $156.76 | -27.3K | 75.2K | -27% | -$4.28M |
| D | 2024-02-13 17:18 | 2024-02-09 | JNJ | Duato Joaquin | CEO, COB, Dir | M - OptEx | $90.44 | +131.0K | 439.3K | +42% | +$11.84M |
| D | 2024-02-13 17:18 | 2024-02-09 | JNJ | Duato Joaquin | CEO, COB, Dir | F - Tax | $156.76 | -98.7K | 340.6K | -22% | -$15.47M |
| DM | 2024-02-12 19:25 | 2024-02-08+ | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | M - OptEx | $85.08 | +63.1K | 200.8K | +46% | +$5.37M |
| D | 2024-02-12 19:25 | 2024-02-08 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | F - Tax | $156.33 | -1,913 | 141.4K | -1% | -$299.1K |
| D | 2024-02-12 19:25 | 2024-02-09 | JNJ | Taubert Jennifer L | EVP, WW COB, Pharmaceuticals | S - Sale+OE | $156.27 | -59.4K | 141.4K | -30% | -$9.28M |
| D | 2024-02-12 19:25 | 2024-02-08 | JNJ | Duato Joaquin | CEO, COB, Dir | M - OptEx | $0.00 | +5,225 | 310.6K | +2% | $0 |
| D | 2024-02-12 19:25 | 2024-02-08 | JNJ | Duato Joaquin | CEO, COB, Dir | F - Tax | $156.33 | -2,269 | 308.3K | -0.7% | -$354.7K |
| D | 2024-02-12 19:25 | 2024-02-08 | JNJ | Wengel Kathryn E | EVP, Chief TO, Risk Off | M - OptEx | $0.00 | +1,971 | 67.9K | +3% | $0 |
| D | 2024-02-12 19:25 | 2024-02-08 | JNJ | Wengel Kathryn E | EVP, Chief TO, Risk Off | F - Tax | $156.33 | -1,009 | 66.9K | -1% | -$157.7K |
| D | 2024-02-12 19:25 | 2024-02-08 | JNJ | Wolk Joseph J | EVP, CFO | M - OptEx | $0.00 | +3,686 | 53.9K | +7% | $0 |
| D | 2024-02-12 19:25 | 2024-02-08 | JNJ | Wolk Joseph J | EVP, CFO | F - Tax | $156.33 | -1,047 | 52.9K | -2% | -$163.7K |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Forminard Elizabeth | GC, Executive VP | M - OptEx | $0.00 | +979 | 6,463 | +18% | $0 |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Forminard Elizabeth | GC, Executive VP | F - Tax | $156.33 | -363 | 6,100 | -6% | -$56.7K |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Swanson James D. | See Remarks | M - OptEx | $0.00 | +1,868 | 11.1K | +20% | $0 |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Swanson James D. | See Remarks | F - Tax | $156.33 | -554 | 10.6K | -5% | -$86.6K |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Schmid Timothy | EVP, WW COB, MedTech | M - OptEx | $0.00 | +1,964 | 10.9K | +22% | $0 |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Schmid Timothy | EVP, WW COB, MedTech | F - Tax | $156.33 | -1,001 | 9,942 | -9% | -$156.5K |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Fasolo Peter | EVP, Chief HR Off | M - OptEx | $0.00 | +2,135 | 104.5K | +2% | $0 |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Fasolo Peter | EVP, Chief HR Off | F - Tax | $156.33 | -781 | 103.7K | -0.7% | -$122.1K |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Hait William | See Remarks | M - OptEx | $0.00 | +3,059 | 34.5K | +10% | $0 |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Hait William | See Remarks | F - Tax | $156.33 | -1,113 | 33.4K | -3% | -$174.0K |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Affairs | M - OptEx | $0.00 | +1,880 | 21.1K | +10% | $0 |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Broadhurst Vanessa | EVP, Gbl Corp Affairs | F - Tax | $156.33 | -703 | 20.4K | -3% | -$109.9K |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Decker Robert J | VP Corp. Ctrl | M - OptEx | $0.00 | +655 | 17.6K | +4% | $0 |
| D | 2024-02-12 19:24 | 2024-02-08 | JNJ | Decker Robert J | VP Corp. Ctrl | F - Tax | $156.33 | -215 | 17.4K | -1% | -$33.6K |
| 2023-08-25 16:07 | 2023-08-23 | JNJ | Hait William | See Remarks | D - Sale to Iss | $0.00 | -696 | 87.1K | -0.8% | $0 | |
| 2023-08-25 16:07 | 2023-08-23 | JNJ | McEvoy Ashley | EVP, WW COB, MedTech | D - Sale to Iss | $0.00 | -2,787 | 52.0K | -5% | $0 | |
| 2023-08-25 16:07 | 2023-08-23 | JNJ | Fasolo Peter | EVP, Chief HR Off | D - Sale to Iss | $0.00 | -232 | 102.5K | -0.2% | $0 | |
| 2023-08-25 16:07 | 2023-08-23 | JNJ | Duato Joaquin | CEO, COB, Dir | D - Sale to Iss | $0.00 | -11.0K | 305.4K | -3% | $0 | |
| 2023-08-25 16:07 | 2023-08-23 | JNJ | Wolk Joseph J | EVP, CFO | D - Sale to Iss | $0.00 | -67 | 50.3K | -0.1% | $0 | |
| 2023-07-27 17:52 | 2023-07-25 | JNJ | Fasolo Peter | EVP, Chief HR Off | S - Sale | $170.32 | -20.0K | 102.7K | -16% | -$3.41M | |
| D | 2023-07-27 17:52 | 2023-07-26 | JNJ | Hait William | See Remarks | M - OptEx | $90.44 | +14.7K | 102.4K | +17% | +$1.33M |
| D | 2023-07-27 17:52 | 2023-07-26 | JNJ | Hait William | See Remarks | S - Sale+OE | $172.00 | -14.7K | 87.7K | -14% | -$2.53M |
| 2023-06-14 16:19 | 2023-06-12 | JNJ | Wengel Kathryn E | EVP, Chief TO, Risk Off | S - Sale | $160.00 | -12.5K | 65.9K | -16% | -$1.99M | |
| 2023-05-25 16:52 | 2023-05-24 | JNJ | Wolk Joseph J | EVP, CFO | G - Gift | $0.00 | -55 | 50.3K | -0.1% | $0 | |
| 2023-03-08 16:16 | 2023-03-06 | JNJ | Swanson James D. | See Remarks | S - Sale | $154.66 | -1,062 | 9,215 | -10% | -$164.2K |
Purchase Sale Sale after option exercise All abbreviations